SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-030473
Filing Date
2020-03-09
Accepted
2020-03-09 08:00:19
Documents
3
Period of Report
2020-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2012067-1_8k.htm 8-K 17186
2 EXHIBIT 99.1 tm2012067d1_ex99-1.htm EX-99.1 149936
3 GRAPHIC tm2012067d1_ex99-1.jpg GRAPHIC 10603
  Complete submission text file 0001104659-20-030473.txt   182982
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 20696577
SIC: 2834 Pharmaceutical Preparations